Burkitt lymphomas failing dose-adjusted R-EPOCH (DA-R-EPOCH)

Ann Hematol. 2014 Jan;93(1):177-8. doi: 10.1007/s00277-013-1771-8. Epub 2013 May 2.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Burkitt Lymphoma / drug therapy*
  • Burkitt Lymphoma / radiotherapy
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Dose-Response Relationship, Drug
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Fatal Outcome
  • Female
  • Humans
  • Lymphoma, AIDS-Related / drug therapy
  • Male
  • Multiple Organ Failure / etiology
  • Prednisone / administration & dosage
  • Treatment Failure
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • EPOCH protocol